Document is current
Any future updates will be listed below
-
Authors
Quaranta, Luciano https://orcid.org/0000-0002-5462-1713
Galbussera, Alessia A. https://orcid.org/0000-0003-0163-1034
Tettamanti, Mauro https://orcid.org/0000-0001-7345-0887
Novella, Alessio https://orcid.org/0000-0001-5927-811X
Pasina, Luca https://orcid.org/0000-0002-4777-1350
Fortino, Ida https://orcid.org/0009-0005-6006-0376
Leoni, Olivia https://orcid.org/0000-0002-6906-2424
Oddone, Francesco https://orcid.org/0000-0002-2504-0004
Giammaria, Sara https://orcid.org/0000-0002-5260-0126
Kużniak, Mikołaj https://orcid.org/0009-0006-4822-4291
Weinreb, Robert N. https://orcid.org/0000-0001-9553-3202
Nobili, Alessandro https://orcid.org/0000-0002-7813-0572
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 5 June 2025
First Online: 3 July 2025
Declarations
:
: Luciano Quaranta received payment honoraria for educational events by Thea, Abbvie and Omikron. Robert N Weinreb received grants from NIH and Research to Prevent Blindness. Luciano Quaranta is an Editorial Board member of Advances in Therapy. Luciano Quaranta was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. Alessia A. Galbussera, Mauro Tettamanti, Alessio Novella, Luca Pasina, Ida Fortino, Olivia Leoni, Francesco Oddone, Sara Giammaria, Mikołaj Kużniak, and Alessandro Nobili have nothing to disclose.
: According to the Italian law, studies using anonymous data from administrative databases that do not involve direct access to individual patient data need no approval from or notification by an ethics committee/institutional review board, and informed patient consent is not required. All data were managed according to Italian law on privacy.
